Relevant Gold raises CAD 5.1 million in first tranche of private placement
Regencell Bioscience Holdings Ltd.
Regencell Bioscience Holdings Ltd. RGC | 0.00 |
- Relevant Gold closed first tranche of non-brokered private placement, issuing 10,298,550 common shares at CAD 0.5 for gross proceeds of CAD 5.1 million.
- Financing is being completed in multiple tranches via concurrent private placement, LIFE offering under NI 45-106.
- Second tranche is expected to close on or about April 10, 2026, with Kinross Gold and William Bollinger expected to participate.
- Proceeds are earmarked for exploration, project advancement, general corporate purposes.
- Concurrent private placement shares carry a four-month Canadian resale restriction expiring Aug. 8, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relevant Gold Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202604071840ACCESSWRNAPR_____1155688) on April 07, 2026, and is solely responsible for the information contained therein.
